Clinical Trial Update: To Evaluate the Efficacy and Safety of DW1903 in Acute and Chronic Gastritis Patient [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating DW1903 for efficacy and safety in acute and chronic gastritis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastritis Acute
• Gastritis Chronic

Drugs mentioned

• DW1903

Snippet

Sponsor: Daewon Pharmaceutical Co., Ltd. | Conditions: Gastritis Acute, Gastritis Chronic | Phase 3 | Status: COMPLETED